RESOURCES

Download these resources to learn more about PAMA reform

Dear Colleague Letter by Reps. Hudson and Peters

Download

Patient Letter in Support of RESULTS Act

Download

Provider Letter in Support of RESULTS Act

Download

Legislative Tracker

Download

Fact Sheet

Download

Detailed Summary

Download

PAMA Legal Challenge

Download
Share these graphics and messages on social media and help spread the word.

Clinical laboratory services play a key role in early detection and treatment. Absent congressional action, these tests will face additional payment cuts, thwarting access and innovation. Tell Congress to #StopLabCuts and pass the #RESULTSAct this year: stoplabcuts.org.

Unless Congress intervenes, a fourth round of payment cuts may jeopardize patient access to critical laboratory services. Congress must pass the #RESULTSAct this year and #StopLabCuts: stoplabcuts.org.

Americans rely on lab tests for early detection, diagnosis, and treatment. But Medicare’s current payment system threatens access. Congress must act now. Support the #RESULTSAct to protect patient care and #StopLabCuts: stoplabcuts.org.

Over 30 national provider groups agree – it’s time for Congress to pass the #RESULTSAct to preserve and enhance patient access to critical laboratory services that inform the majority of healthcare decisions. Tell Congress to #StopLabCuts this year: StopLabCuts.org.

More than 30 leading provider groups support the #RESULTSAct, a long-term solution to #StopLabCuts. Congress must act now to protect access for the tens of millions of patients and providers who rely on laboratory tests for diagnosis, monitoring, and treatment: StopLabCuts.org.

Cosponsor @RepJohnJoyce recognizes that the #RESULTSAct is a critical step toward a more sustainable, patient-centered payment system for clinical laboratory testing. Leading patient and provider groups agree – it is time to take action and #StopLabCuts: StopLabCuts.org.

Patients deserve stable access to reliable diagnostic testing. #RESULTSAct cosponsor @RepGusBilirakis understands the importance of safeguarding laboratory services to ensure patients can get answers to their health questions. Congress must #StopLabCuts: StopLabCuts.org.

Breakthrough diagnostic testing is only meaningful if patients can access it. Ongoing cuts to laboratory payments threaten progress that is changing rare disease diagnostics. The #RESULTSAct will #StopLabCuts and support future innovation. Ask Congress to act: StopLabCuts.org.

Without Congressional action, about 800 laboratory tests face a 4th round of payment cuts starting January 1, 2027. 30 patient and consumer advocacy groups are asking Congress to foster innovation and preserve access to laboratory tests by passing the #RESULTSAct. Take action: StopLabCuts.org.

Results matter to the providers and patients who rely on clinical laboratory testing to diagnose conditions, inform treatment, and monitor disease progression. Over 60 groups have signed letters to Congress in support of the #RESULTSAct to #StopLabCuts. Act now: StopLabCuts.org.

Clinical laboratory testing can provide answers for patients with rare diseases and their families sooner, allowing them to move forward with confidence through treatment planning and disease management. The RESULTS Act will protect patient access to these critical tests.

Advanced clinical laboratory testing can help providers make decisions about whether their patients require chemotherapy as part of their breast cancer treatment. The RESULTS Act will ensure patients maintain access to timely, crucial laboratory testing.

Genomic testing arms providers with information to guide the best course of treatment for their patients, optimizing prescribing for patients on antidepressants. The RESULTS Act will support innovation in clinical laboratory testing that informs personalized care.

Informational videos about how medicare payment cuts threaten access to clinical lab services and undermine our nation’s laboratory infrastructure.

TAKE ACTION

 

Tell Congress to stop Medicare cuts to clinical laboratory testing.